
Sign up to save your podcasts
Or


Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are rapidly evolving. Are you up to date on the evidence? Credit available for this activity expires: 09/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are rapidly evolving. Are you up to date on the evidence? Credit available for this activity expires: 09/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu

1,259 Listeners

320 Listeners

500 Listeners

303 Listeners

1,392 Listeners

179 Listeners

899 Listeners

14 Listeners

16 Listeners

298 Listeners

3,376 Listeners

8,724 Listeners

196 Listeners

515 Listeners

369 Listeners

62 Listeners

26 Listeners

431 Listeners